GlassScriptPhysician profile
David T Rudman
NPI 1558326199
$17,875.97
in general payments reported to CMS, 2019-2025
30 companies · $1,590 in 2025
The $1,590 reported for 2025 was more than what 87% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,533 · 2020: $854 · 2021: $1,645 · 2022: $1,595 · 2023: $1,036 · 2024: $1,623 · 2025: $1,590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,248.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,591.42 | 2019-2020 | |
| Aerin Medical INC. | $2,223.60 | 2019-2025 | |
| Intersect Ent, INC. | $1,813.99 | 2019-2022 | |
| Stryker Corporation | $925.42 | 2019-2024 | Scopis Ent, Xpress Ent Dilation System |
| Genzyme Corporation | $918.63 | 2020-2025 | |
| Inspire Medical Systems, INC. | $738.22 | 2022-2025 | Inspire |
| Optinose US, INC. | $662.03 | 2020-2025 | |
| Glaxosmithkline, LLC. | $659.73 | 2021-2025 | Nucala |
| Neurent Medical Limited | $375.39 | 2024-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
| Acclarent, INC | $322.32 | 2019-2023 | Acclarent Aera |
| Regeneron Healthcare Solutions, INC. | $308.55 | 2020-2025 | Dupixent |
| Medtronic, INC. | $236.01 | 2023-2025 | Propel |
| Smith+Nephew, INC. | $172.27 | 2021-2025 | Halo, Tula, Ent Sinus |
| Medtronic USA, INC. | $152.20 | 2019 | |
| Olympus America INC. | $148.99 | 2019-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $111.58 | 2019 | |
| Integra Lifesciences Corporation | $86.74 | 2024-2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Hologic Sales and Service, LLC | $64.63 | 2023-2024 | Coolseal Generator |
| Merck Sharp & Dohme LLC | $40.41 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $37.83 | 2025 | |
| Arbor Pharmaceuticals, INC. | $37.55 | 2019-2020 | |
| Innovation Technologies INC | $37.02 | 2023 | Irrisept |
| Novartis Pharmaceuticals Corporation | $35.28 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $31.96 | 2022 | |
| Covidien LP | $31.94 | 2019 | |
| Amgen INC. | $26.22 | 2025 | Tezspire |
| Sanofi-Aventis U.S. LLC | $25.05 | 2022 | |
| Ambu INC. | $24.90 | 2024 | |
| Allergan, INC. | $24.00 | 2019 | |
| Pfizer INC. | $12.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rudman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.